The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
More on our cookie policy.
The translational approach used brings together researchers in the field of pharmaceutical research and development. Various collaborations have been set up with disease-related programmes and research groups at the University Medical Center Groningen (UMCG). The BDDD research covers all aspects, from drug discovery and design to production, administration, delivery, and toxicology. The programme focuses on:
The BDDD programme works on the improvement of drugs and technologies used in drug development, production, administration, and safety assessment. The emphasis is on therapies for age-related diseases (e.g. fibrotic diseases, COPD, and cancer), in accordance with the UMCG’s focus on healthy ageing.
Collaborations have been set up with other researchers from the GUIDE institute and the UMCG, as well as with external parties, including industrial partners. The top-notch research performed in our programme offers an attractive environment for young, talented researchers and has already yielded concrete results:
University Medical Center Groningen (UMCG)
Institute GUIDE
Biopharmaceuticals, Discovery, Design and Delivery (BDDD)
P.O. Box 196
9700 AD Groningen
The Netherlands